Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Straumann Holding AGXSWX:STMN -2.67%96 3-Year Book Growth Rate is 5.30% as of Dec. 2025, which is 33% below its 10-year median of 7.90. GuruFocus rates XSWX:STMN with a GF Score™ of 96/100 and a GF Value™ of CHF137.97 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 762 Medical Devices & Instruments companies, Straumann Holding AG ranks better than 61.02% on this metric.
During the past 12 months, Straumann Holding AG's average Book Value per Share Growth Rate was 5.90% per year.
During the past 3 years, the average Book Value per Share Growth Rate was 5.30% per year.
During the past 5 years, the average Book Value per Share Growth Rate was 11.50% per year.
During the past 10 years, the average Book Value per Share Growth Rate was 12.90% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.
During the past 13 years, the highest 3-Year average Book Value per Share Growth Rate of Straumann Holding AG was 30.10% per year. The lowest was -2.90% per year. And the median was 7.90% per year.
Straumann Holding AG (XSWX:STMN) 3-Year Book Growth Rate Explanation
Book Value per Share is the ratio of equity available to common shareholders divided by the shares outstanding. Book value per share effectively indicates a firm's net asset value on a per-share basis. It can be used by investors to gauge whether a stock price is undervalued by comparing it to the firm's market value per share. Theoretically, it is what the shareholders will receive if the company is liquidated.
Straumann Holding AG 3-Year Book Growth Rate Related Terms
XSWX:STMN vs ISRG, BDX, MDLN: 3-Year Book Growth Rate Comparison
For the Medical Instruments & Supplies subindustry, Straumann Holding AG's 3-Year Book Growth Rate, along with its competitors' market caps and 3-Year Book Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Straumann Holding AG 3-Year Book Growth Rate vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Straumann Holding AG's 3-Year Book Growth Rate distribution charts can be found below:
* The bar in red indicates where Straumann Holding AG's 3-Year Book Growth Rate falls into.
Straumann Holding AG 3-Year Book Growth Rate Calculation
This is the 3-year average growth rate of Book Value per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.
What does a 3-Year Book Growth Rate of 5.30% mean?
Straumann Holding AG (XSWX:STMN) has a 3-Year Book Growth Rate of 5.30% as of Dec. 2025. 3-Year Book Growth Rate is the 3-year average growth rate of Book Value per Share. View historical data for Straumann Holding AG and its competitors. This is 33% below median its historical median of 7.90. According to the industry distribution chart, Straumann Holding AG ranks #297 out of 762 companies in the Medical Devices & Instruments industry, placing it in the top 39%.
Is Straumann Holding AG's 3-Year Book Growth Rate too high?
Straumann Holding AG's current 3-Year Book Growth Rate of 5.30% is 33% below median its 10-year median of 7.90. The Medical Devices & Instruments industry median 3-Year Book Growth Rate is 2.35. Straumann Holding AG's value of 5.30% is 125.5% above this industry median. Based on the distribution chart, Straumann Holding AG ranks #297 out of 762 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Straumann Holding AG has a GF Score™ of 96/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Straumann Holding AG's 3-Year Book Growth Rate compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Straumann Holding AG ranks #297 out of 762 companies for 3-Year Book Growth Rate. This puts Straumann Holding AG in the upper half of its industry. The industry median 3-Year Book Growth Rate is 2.35. Straumann Holding AG's value of 5.30% is 125.5% above this benchmark. While the company's 10-year median is 7.90 vs. the industry median of 2.35, Straumann Holding AG has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year Book Growth Rate for a Medical Devices & Instruments company?
The median 3-Year Book Growth Rate among Medical Devices & Instruments companies is 2.35, based on 762 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year Book Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year Book Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Straumann Holding AG's current 3-Year Book Growth Rate of 5.30% is 125.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year Book Growth Rate mean?
A high 3-Year Book Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year Book Growth Rate is the 3-year average growth rate of Book Value per Share. View historical data for Straumann Holding AG and its competitors. For the Medical Devices & Instruments industry, the median 3-Year Book Growth Rate is 2.35 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Straumann Holding AG's current 3-Year Book Growth Rate is 5.30%, which is 33% below median its own 10-year median of 7.90. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Straumann Holding AG stock overvalued right now?
Based on GuruFocus' analysis, Straumann Holding AG (XSWX:STMN) is currently considered Modestly Undervalued. The stock's GF Value™ is CHF137.97, compared to a current price of CHF102.20 — trading 25.9% below its estimated fair value. The current 3-Year Book Growth Rate is 5.30%, which is 33% below median its 10-year median of 7.90 and 125.5% above the Medical Devices & Instruments industry median of 2.35. Straumann Holding AG's overall GF Score™ is 96/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year Book Growth Rate calculated?
3-Year Book Growth Rate is calculated from a company's financial statements. For Straumann Holding AG (XSWX:STMN), the current 3-Year Book Growth Rate is 5.30% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Straumann Holding AG (XSWX:STMN) Overvalued in 2026?
Based on GuruFocus' analysis, Straumann Holding AG stock appears to be undervalued.
The current stock price of CHF102.20 is trading 25.9% below its estimated GF Value™ of CHF137.97.
GuruFocus considers Straumann Holding AG to be Modestly Undervalued.
Key valuation signals for XSWX:STMN:
3-Year Book Growth Rate: 5.30% (33% below median its 10-year median of 7.90)
GF Value™: CHF137.97 vs. price of CHF102.20 (25.9% below fair value)
Industry Position: 125.5% above the Medical Devices & Instruments median (#297 of 762)
No single metric tells the full story. See the XSWX:STMN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Straumann is a global leader in tooth replacement and orthodontics solutions. Its line of products includes dental implants, abutments, clear aligners, biomaterials, and computer-aided design/computer-aided manufacturing equipment. The firm's core products are dental implants, and it holds over one third of the CHF 6 billion global market. Originally a pure premium implant player, Straumann entered the value market in 2012 with its acquisition of Neodent. Straumann now accounts for almost half of the global premium market and around 15% of the value market. While its premium product catalog is marketed under Straumann, its value brands include Neodent, Anthogyr, and Medentika as well as other local and regional brands.
96GF Score
Get the complete analysis for XSWX:STMN
3-Year Book Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:STMN has been successfully added to your 
